Published in Methods Find Exp Clin Pharmacol on January 01, 2002
The place of electrophysiology in the proof of concept approach of psychotropic drug development. Methods Find Exp Clin Pharmacol (2002) 0.75
Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation. Sleep Med (2006) 1.44
First-night effect in normal subjects and psychiatric inpatients. Sleep (1995) 1.34
Sleep stage scoring using the neural network model: comparison between visual and automatic analysis in normal subjects and patients. Sleep (1996) 1.05
Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol (2008) 1.03
Changes in EEG power density during sleep laboratory adaptation. Sleep (1997) 1.01
Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology (Berl) (2007) 0.95
Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential. Neuropsychobiology (1999) 0.92
Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence. Neuropsychobiology (2004) 0.85
Temporal relationships between pulsatile cortisol secretion and electroencephalographic activity during sleep in man. Electroencephalogr Clin Neurophysiol (1997) 0.83
Temporal relationship between prolactin secretion and slow-wave electroencephalic activity during sleep. Sleep (1995) 0.82
Periodic limb movements and obstructive sleep apneas before and after continuous positive airway pressure treatment. J Sleep Res (1999) 0.81
Temporal link between plasma thyrotropin levels and electroencephalographic activity in man. Neurosci Lett (1995) 0.81
A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology (Berl) (2005) 0.81
Psychotropic profile of S 17092, a prolyl endopeptidase inhibitor, using quantitative EEG in young healthy volunteers. Neuropsychobiology (2007) 0.80
Relationships between intact parathyroid hormone 24-hour profiles, sleep-wake cycle, and sleep electroencephalographic activity in man. J Clin Endocrinol Metab (1996) 0.80
Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.80
All-night EEG spectral analysis as a tool for the prediction of clinical response to antidepressant treatment. Biol Psychiatry (1995) 0.79
Alpha activity and cardiac correlates: three types of relationships during nocturnal sleep. Clin Neurophysiol (2000) 0.79
Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge. J Psychopharmacol (2009) 0.79
Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers. Addict Behav (2005) 0.78
Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man. J Psychopharmacol (2007) 0.78
Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers. Eur Neuropsychopharmacol (2001) 0.78
IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group. Neuropsychobiology (1999) 0.78
Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers. J Clin Pharmacol (2006) 0.78
Statistical Decision Tree: a tool for studying pharmaco-EEG effects of CNS-active drugs. Neuropsychobiology (1994) 0.77
Effect of moclobemide on the psychophysiology of sleep/wake cycles: a neuroelectrophysiological study of depressed patients administered with moclobemide. Int Clin Psychopharmacol (1993) 0.77
[Neuro-electrophysiologic studies in abstinent and depressed alcoholic patients treated with tianeptine]. Presse Med (1991) 0.76
5-HT2 receptors are partially involved in the relationship between renin release and delta relative power. J Endocrinol Invest (1996) 0.76
Changes in EEG power density during sleep laboratory adaptation in depressed inpatients. Biol Psychiatry (2000) 0.76
[Development of compounds active in insomnia: recent developments and methodological aspects]. Rev Neurol (Paris) (2003) 0.75
[Algodystrophy and venous thrombosis of the lower limbs: diagnostic problems. Apropos of 5 cases]. Rev Rhum Mal Osteoartic (1989) 0.75
An architecture for EEG signal processing and interpretation during sleep (ESPIS). Comput Methods Programs Biomed (1994) 0.75
Low-dimensional dynamic self-organization in delta-sleep: effect of partial sleep deprivation. Biol Cybern (1996) 0.75
A statistical evaluation of the main interpolation methods applied to 3-dimensional EEG mapping. Electroencephalogr Clin Neurophysiol (1991) 0.75
Characterization of the CNS effects of naftidrofuryl (Praxilène) by quantitative EEG and functional MRI: a study in healthy elderly subjects. Neuropsychobiology (2003) 0.75
[Apparently isolated macrodactyly of the toe with localized angiodysplasia. 2 cases]. Ann Med Interne (Paris) (1989) 0.75